This compound is a phosphoramidite monomer used as a building block in oligonucleotide synthesis. It features a complex structure with multiple aromatic rings, ether linkages, and a phosphoramidite group, making it suitable for solid-phase DNA/RNA assembly.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 199593-09-4
2'-OMe-Bz-C Phosphoramidite
Oligonucleotide synthesis building block
Ac-rC Phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
Phosphoramidite for oligonucleotide synthesis
(2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
1-Bromo-4-chloro-2-fluorobenzene
Pharmaceutical intermediate
4-[[[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyl]amino]benzoic acid
Pharmaceutical intermediate
N-Fmoc-4-Cyclopropyl-L-phenylalanine
Protected amino acid for peptide synthesis
HCV-IN-31
HCV antiviral intermediate
N-[1-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
WNWUMIPFLOKTEZ-MNVCMFJRSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H]1[C@H](O[C@H]([C@H]1OC)N2C=CC(=NC2=O)NC(=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC